The PRIMARY study demonstrated that the addition of PSMA PET can improve the sensitivity and negative predictive value of an MRI [21], and that a 5-point PRIMARY score can provide high diagnostic accuracy for clinically significant (Grade Group 2 and above) prostate cancer [22]. The gene discussed is FOLH1; the disease is prostate cancer.